Collplant Holdings (CLGN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CollPlant Biotechnologies has reported promising pre-clinical results for its innovative 3D-printed regenerative breast implants, designed to address a $3 billion market. Despite a decline in revenue, the company is actively pursuing collaborations to leverage its rhCollagen technology, aiming to enhance its financial position and advance its development programs.
For further insights into CLGN stock, check out TipRanks’ Stock Analysis page.
